Medicare Enrolled

Joycelyn Martin Walcott, AGACNP

Acute Care Nurse Practitioner · Shenandoah, TX
18354 INTERSTATE 45 S STE 200, Shenandoah, TX 77384
9362357092
Registered in NPPES since 2021
NPI: 1841953189 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Martin Walcott from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Martin Walcott? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Martin Walcott

Joycelyn Martin Walcott is an acute care nurse practitioner in Shenandoah, TX, with 4 years of NPI registration.

Between the years covered by Open Payments, Martin Walcott received a total of $2,513 from 31 pharmaceutical and/or device companies across 104 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Martin Walcott is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 4 years of NPI registration $2,513 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$2,513
Total received (2022-2024)
Avg $838/year across 3 years
Top 11% in TX for acute care nurse practitioner
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
104
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$316
2023
$1,545
2022
$653

Payments by company (2024)

Myriad Genetic Laboratories, Inc.
$90
Novartis Pharmaceuticals Corporation
$48
Amneal Pharmaceuticals LLC
$30
Rigel Pharmaceuticals, Inc.
$26
Janssen Biotech, Inc.
$25
Merck Sharp & Dohme LLC
$24
Takeda Pharmaceuticals U.S.A., Inc.
$23
TAIHO ONCOLOGY, INC.
$19
Aveo Pharmaceuticals, Inc.
$18
Astellas Pharma US Inc
$13
Top 3 companies account for 53.3% of 2024 payments
All-time payments by company (2022-2024) ›
Astellas Pharma US Inc
$366
Novartis Pharmaceuticals Corporation
$275
Seagen Inc.
$218
Janssen Biotech, Inc.
$170
Rigel Pharmaceuticals, Inc.
$169
Amgen Inc.
$128
Celgene Corporation
$96
Myriad Genetic Laboratories, Inc.
$90
Blueprint Medicines Corporation
$89
Merck Sharp & Dohme LLC
$83
Alexion Pharmaceuticals, Inc.
$83
Lilly USA, LLC
$77
PFIZER INC.
$73
MorphoSys, US Inc.
$56
Pharmacyclics LLC, An AbbVie Company
$56
CTI BioPharma Corp.
$55
Takeda Pharmaceuticals U.S.A., Inc.
$50
Daiichi Sankyo Inc.
$42
E.R. Squibb & Sons, L.L.C.
$40
TAIHO ONCOLOGY, INC.
$34
Taiho Oncology, Inc.
$31
Janssen Pharmaceuticals, Inc
$31
Amneal Pharmaceuticals LLC
$30
Sumitomo Pharma America, Inc.
$28
Deciphera Pharmaceuticals Inc.
$27
ABBVIE INC.
$26
PharmaEssentia USA Corporation
$21
G1 Therapeutics, Inc.
$19
Aveo Pharmaceuticals, Inc.
$18
Mirati Therapeutics, Inc.
$17
PUMA BIOTECHNOLOGY, INC.
$13
Top 3 companies account for 34.2% of all-time payments
Associated products mentioned in payments ›
ALUNBRIG · AVASTIN · AYVAKIT · BESREMI · Blincyto · COSELA · CYRAMZA · DARZALEX · ELIQUIS · EPKINLY · ERLEADA · Enhertu · FOTIVDA · Fabhalta · IBRANCE · IMBRUVICA · INJECTAFER · KEYTRUDA · KISQALI · KRAZATI · LONSURF · MONJUVI · NERLYNX · Nplate · OPDIVO · OPDUALAG · ORGOVYX · PIQRAY · PROLARIS · PROMACTA · Padcev · Pomalyst · QINLOCK · REBLOZYL · Repatha · Rezlidhia · SCEMBLIX · TUKYSA · Tavalisse · ULTOMIRIS · VENCLEXTA · VERQUVO · VERZENIO · Vonjo · XALKORI · XARELTO · Xospata
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an acute care nurse practitioner in Shenandoah?
Compare acute care nurse practitioners in the Shenandoah area by procedure volume, costs, and industry payment transparency.
Browse acute care nurse practitioners nearby

Geographic Context

Acute care nurse practitioners in nearby ZIP areas
163
County median income
$97,266
Nearest hospital to ZIP centroid (approximate)
ST LUKE'S THE WOODLANDS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Martin Walcott is an acute care nurse practitioner.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Martin Walcott receive payments from pharmaceutical companies?
Yes. Martin Walcott received a total of $2,513 from 31 companies across 104 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Martin Walcott) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →